These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 34353224)
1. Predictive models for adverse clinical outcomes in Chinese patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting. Zheng JY; Cao Y; Li DT; Qiu YG; Zhao L; Xu ZM; Huang YX; Hong ZB; Li TC; Tang YD; Guo CJ; Ma ZM; Wu YQ; Chen Y Acta Cardiol; 2022 Jun; 77(4):360-365. PubMed ID: 34353224 [TBL] [Abstract][Full Text] [Related]
2. CHA2DS2-VASc score as a prognostic indicator in patients with atrial fibrillation undergoing coronary stenting. Zheng JY; Li DT; Qıu YG; Huang YX; Xu ZM; Zhao L; Chen Y; Cao Y; Tang YD; Guo CJ; Ma ZM; Wu YQ; Jıao Y; Li TC Turk J Med Sci; 2022 Aug; 52(4):1103-1110. PubMed ID: 36326398 [TBL] [Abstract][Full Text] [Related]
3. Bleeding and Subsequent Cardiovascular Events and Death in Atrial Fibrillation With Stable Coronary Artery Disease: Insights From the AFIRE Trial. Kaikita K; Yasuda S; Akao M; Ako J; Matoba T; Nakamura M; Miyauchi K; Hagiwara N; Kimura K; Hirayama A; Matsui K; Ogawa H Circ Cardiovasc Interv; 2021 Nov; 14(11):e010476. PubMed ID: 34474583 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention. Guo T; Xi Z; Qiu H; Wang Y; Zheng J; Dou K; Xu B; Qiao S; Yang W; Gao R Ann Med; 2021 Dec; 53(1):2215-2224. PubMed ID: 34791980 [TBL] [Abstract][Full Text] [Related]
5. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Friberg L; Rosenqvist M; Lip GY Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443 [TBL] [Abstract][Full Text] [Related]
7. [Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study]. Zhu LY; Li Q; Yu LY; Liu Y; Chen YN; Wang Z; Zhang SY; Li J; Liu Y; Zhao YL; Xi Y; Pi L; Sun YH Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):731-741. PubMed ID: 37460427 [No Abstract] [Full Text] [Related]
8. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of ST-segment elevation myocardial infarction in patients with atrial fibrillation, prior stenting and long-standing chronic coronary syndrome. Franchina AG; Calderone D; D'Arrigo P; Ingala S; Milluzzo RP; Greco A; Spagnolo M; Tamburino C; Capodanno D Cardiol J; 2020; 27(1):8-15. PubMed ID: 31960945 [TBL] [Abstract][Full Text] [Related]
10. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study. Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE; Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437 [TBL] [Abstract][Full Text] [Related]
12. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744 [TBL] [Abstract][Full Text] [Related]
13. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study. Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001 [TBL] [Abstract][Full Text] [Related]
14. Performance of the ATRIA Bleeding Score in Predicting the Risk of In-Hospital Bleeding in Patients with ST-Elevation or Non-ST-Elevation Myocardial Infarction. Yavuz F; Kaplan M; Yildirim A; Genc O; Asoglu R; Afsin A; Hosoglu Y; Kilic S Braz J Cardiovasc Surg; 2023 Feb; 38(1):139-148. PubMed ID: 35675497 [TBL] [Abstract][Full Text] [Related]
15. CHA2DS2-VASc Score as a Predictor of Adverse Outcomes after Ischemic Stroke in Patients without Atrial Fibrillation. Aker A; Volis I; Saliba W; Naoum I; Zafrir B Isr Med Assoc J; 2024 Mar; 26(3):143-148. PubMed ID: 38493324 [TBL] [Abstract][Full Text] [Related]
16. Warfarin therapy in Chinese patients with atrial fibrillation treated with percutaneous coronary intervention: a 5 year follow-up retrospective cohort study. Li Y; Liu W; Liu X; Shen H; Hou F; Jin P; Xi Z; Zhou Y Curr Med Res Opin; 2019 Oct; 35(10):1777-1783. PubMed ID: 31144555 [No Abstract] [Full Text] [Related]
17. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809 [TBL] [Abstract][Full Text] [Related]
18. Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention. Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM Thromb Res; 2022 Jan; 209():16-22. PubMed ID: 34844044 [TBL] [Abstract][Full Text] [Related]
19. Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study. Anguita Sánchez M; Marín F; Masjuan J; Cosín-Sales J; Vázquez Rodríguez JM; Barrios V; Barón-Esquivias G; Lekuona I; Pérez-Cabeza AI; Freixa-Pamias R; Parra Jimenez FJ; Monzer Khanji Khatib M; Rafols Priu C; Sanmartín Fernández M Cardiol J; 2022; 29(6):936-947. PubMed ID: 36200548 [TBL] [Abstract][Full Text] [Related]
20. Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study). Lip GYH; Merino JL; Dan GA; Themistoclakis S; Ellenbogen KA; De Caterina R; Goudev A; Jin J; Melino M; Winters SM; Goette A Am J Cardiol; 2018 Jan; 121(2):193-198. PubMed ID: 29169605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]